Suppr超能文献

日本免疫球蛋白A肾病的自然病史及危险因素。进行性肾病研究组。

Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.

作者信息

Koyama A, Igarashi M, Kobayashi M

机构信息

Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

Am J Kidney Dis. 1997 Apr;29(4):526-32. doi: 10.1016/s0272-6386(97)90333-4.

Abstract

The Research Group on Progressive Renal Diseases conducted a national survey, in Japan, of cases of primary glomerulonephritis (GN) in 1985 and 1993. The results of the survey, reported here, revealed a high prevalence and relatively poor prognosis for immunoglobulin A nephropathy (IgAN). Using immunofluorescent microscopy, 47.2% of 1,063 patients were diagnosed as having IgAN; 62.8% of patients had diffuse mesangial proliferative GN, and focal mesangial proliferative GN was observed in 23.0%. Nearly 70% of the patients had no clinical symptoms, and the IgAN was detected by routine physical examination. The mean period of observation was 11.8 +/- 6.3 years. Renal survival rates for the 502 cases of IgAN, in which the start of dialysis and renal-related death were end points, were 96%, 85%, 75%, and 61% at 5, 10, 15, and 20 years, respectively, from the time of the detection of the earliest known renal abnormalities. Renal survival rates of patients with diffuse mesangial proliferative GN were 96%, 83%, 75%, and 59% at 5, 10, 15, and 20 years, respectively. At the end of the observation period, 20% of patients had improved, 45.8% showed no change, 13.5% had deteriorated, and 20.4% had renal-related death. The risk factors for renal failure by logistic multivariate analysis were serum creatinine concentration > or =1.4 mg/dL (relative risk, 3.5) and levels of urinary protein > or = +(dipstick) (relative risk, 6.4), determined at the time of biopsy. These parameters can be useful for assessing prognosis during the relatively advanced stages of this disease. It is important to note that a relatively high percentage of patients with IgAN progressed to end-stage renal failure even when their histologic findings comprised only minor glomerular abnormalities or focal proliferative changes.

摘要

进行性肾病研究小组于1985年和1993年在日本对原发性肾小球肾炎(GN)病例进行了全国性调查。本文报道的调查结果显示,免疫球蛋白A肾病(IgAN)的患病率较高且预后相对较差。采用免疫荧光显微镜检查,1063例患者中有47.2%被诊断为IgAN;62.8%的患者患有弥漫性系膜增生性GN,23.0%观察到局灶性系膜增生性GN。近70%的患者无临床症状,IgAN通过常规体检被发现。平均观察期为11.8±6.3年。以开始透析和与肾相关的死亡为终点,502例IgAN患者从最早已知的肾脏异常被检测出时起,5年、10年、15年和20年的肾脏存活率分别为96%、85%、75%和61%。弥漫性系膜增生性GN患者的肾脏存活率在5年、10年、15年和20年分别为96%、83%、75%和59%。在观察期末,20%的患者病情好转,45.8%无变化,13.5%病情恶化,20.4%发生与肾相关的死亡。经逻辑多变量分析,活检时血清肌酐浓度≥1.4mg/dL(相对风险,3.5)和尿蛋白水平≥ +(试纸法)(相对风险,6.4)是肾衰竭的危险因素。这些参数可用于评估该疾病相对晚期的预后。需要注意的是,即使IgAN患者的组织学表现仅为轻微的肾小球异常或局灶性增生性改变,仍有相当比例的患者进展至终末期肾衰竭。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验